Makoto Murakami Selected Research

Group II Phospholipases A2

1/2016	Dual Roles of Group IID Phospholipase A2 in Inflammation and Cancer.
10/2015	Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.
6/2013	Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators.
2/2005	Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells.
5/2002	Cellular arachidonate-releasing function and inflammation-associated expression of group IIF secretory phospholipase A2.
4/2002	Arachidonate release and eicosanoid generation by group IIE phospholipase A(2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Murakami Research Topics

Disease

37	Inflammation (Inflammations) 04/2022 - 03/2002
23	Neoplasms (Cancer) 04/2022 - 05/2003
14	Atherosclerosis 01/2020 - 03/2002
11	Anaphylaxis (Anaphylactic Shock) 01/2019 - 06/2007
9	Neoplasm Metastasis (Metastasis) 06/2022 - 11/2003
7	Hypersensitivity (Allergy) 04/2022 - 08/2004
7	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 05/2003
6	Carcinogenesis 01/2022 - 05/2003
5	Infections 01/2022 - 01/2006
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2016
5	Stomach Neoplasms (Stomach Cancer) 08/2020 - 10/2005
5	Hyperplasia 01/2020 - 03/2006
4	Dyspepsia (Indigestion) 01/2021 - 01/2018
4	Obesity 01/2020 - 07/2014
3	Chronic Pancreatitis 01/2021 - 01/2018
3	Insulin Resistance 10/2020 - 01/2016
3	Rheumatoid Arthritis 04/2020 - 08/2004
3	Asthma (Bronchial Asthma) 01/2020 - 06/2010
3	Pain (Aches) 01/2019 - 08/2004
3	Carcinoma (Carcinomatosis) 03/2018 - 06/2002
3	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2007
3	Atopic Dermatitis (Atopic Eczema) 12/2011 - 04/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2022 - 03/2018
2	Fibrosis (Cirrhosis) 01/2022 - 10/2020
2	COVID-19 01/2022 - 04/2021
2	Skin Diseases (Skin Disease) 01/2022 - 01/2018
2	Contact Dermatitis (Eczema, Contact) 01/2021 - 06/2013
2	Osteoarthritis 04/2020 - 01/2008
2	Metaplasia 07/2019 - 10/2005
2	Ichthyosis (Xeroderma) 01/2019 - 01/2017
2	Colitis 01/2017 - 03/2016
2	Edema (Dropsy) 02/2014 - 11/2003
2	Pneumonia (Pneumonitis) 08/2013 - 04/2005
2	Hyperglycemia 07/2012 - 01/2009
2	Atherosclerotic Plaque (Atheroma) 12/2011 - 10/2003
2	Necrosis 06/2008 - 04/2005
2	Sigmoid Neoplasms 01/2007 - 11/2003

Drug/Important Bio-Agent (IBA)

32	Secretory Phospholipases A2IBA 01/2022 - 03/2002
23	EnzymesIBA 01/2021 - 03/2002
21	LipidsIBA 01/2022 - 10/2003
14	Phospholipases (Phospholipase)IBA 01/2022 - 06/2002
10	EicosanoidsIBA 01/2022 - 03/2002
8	Phospholipases A2 (Phospholipase A2)IBA 01/2022 - 11/2007
8	Dinoprostone (PGE2)FDA Link 03/2018 - 05/2003
8	CytokinesIBA 03/2016 - 12/2003
7	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 08/2002
7	ProstaglandinsIBA 10/2020 - 12/2003
7	Prostaglandin-E SynthasesIBA 03/2018 - 05/2003
7	Group X Phospholipases A2IBA 03/2016 - 06/2002
6	Group II Phospholipases A2IBA 01/2016 - 04/2002
5	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2004
4	Immunoglobulin E (IgE)IBA 10/2021 - 06/2007
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2020 - 10/2004
4	LeukotrienesIBA 04/2020 - 04/2002
4	LipopolysaccharidesIBA 03/2015 - 04/2002
4	IsoenzymesIBA 11/2006 - 03/2002
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 03/2016
3	Pharmaceutical PreparationsIBA 04/2021 - 01/2006
3	Arachidonic Acid (Vitamin F)IBA 04/2020 - 10/2011
3	Biological ProductsIBA 01/2019 - 06/2010
3	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018 - 12/2011
3	AMP-Activated Protein KinasesIBA 01/2017 - 09/2013
3	InterleukinsIBA 05/2009 - 10/2004
3	Prostaglandins EIBA 12/2005 - 12/2003
2	Messenger RNA (mRNA)IBA 01/2022 - 11/2006
2	Imiquimod (Aldara)FDA LinkGeneric 01/2022 - 01/2020
2	Prostaglandin D2IBA 01/2022 - 02/2012
2	asapiprantIBA 01/2022 - 04/2021
2	Insulin (Novolin)FDA Link 10/2020 - 04/2011
2	protectin D1IBA 04/2020 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 04/2020 - 02/2012
2	Z 338IBA 01/2020 - 01/2019
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020 - 03/2016
2	Leukotriene B4IBA 01/2020 - 10/2016
2	Interleukin-6 (Interleukin 6)IBA 03/2018 - 03/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2018 - 10/2004
2	Sirtuin 1IBA 01/2018 - 01/2017
2	AcidsIBA 01/2018 - 10/2016
2	Dextran SulfateIBA 01/2017 - 03/2016
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 06/2015
2	Oxygen (Dioxygen)IBA 09/2015 - 03/2015
2	varespladibIBA 03/2015 - 03/2013
2	CalpainIBA 03/2015 - 12/2011
2	AntibodiesIBA 07/2014 - 10/2004
2	Phospholipase A2 ReceptorsIBA 01/2014 - 08/2013
2	CollagenIBA 01/2014 - 08/2004
2	Calcium-Independent Phospholipases A2IBA 01/2014 - 10/2010
2	Lipoproteins (Lipoprotein)IBA 06/2011 - 11/2008
2	MucinsIBA 01/2011 - 06/2008
2	Antineoplastic Agents (Antineoplastics)IBA 04/2009 - 10/2005
2	taxaneIBA 06/2008 - 10/2005
2	Small Interfering RNA (siRNA)IBA 01/2008 - 07/2005

Therapy/Procedure

8	Therapeutics 06/2022 - 11/2003
4	Drug Therapy (Chemotherapy) 06/2022 - 10/2005
3	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 11/2003
3	Colectomy 01/2018 - 11/2003
3	Glycemic Control 07/2012 - 01/2009
2	Adjuvant Chemotherapy 08/2020 - 10/2017
2	Pancreaticoduodenectomy 05/2017 - 07/2016
2	Transplantation 07/2012 - 01/2009